Prothrombin 3'end Gene Variants in Patients With Sporadic Colon Adenocarcinoma
Marija Cumbo1, Branko Tomic2, Sofija Dunjic2
1Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia marijacumbo@imgge.bg.ac.rs.
Background/Aim:
Thrombin plays significant roles in various types of cancer. However, the expression levels of prothrombin, the thrombin precursor, in cancer remain unclear. Variants of the 3'end of the prothrombin gene lead to increased prothrombin expression. This study aimed to analyze prothrombin 3'end gene variants in colon tumor and adjacent normal tissue samples.
Materials And Methods:
The study group consisted of 93 patients suffering from colon adenocarcinoma. The 3'end of the prothrombin gene was analyzed by DNA sequencing.
Results:
Three variants, all previously associated with increased prothrombin expression were detected. Frequency of the FII 19911G allele was 46.77% and 47.85% in tumor and normal tissue, respectively. For the FII 20210A allele, the detected frequencies were 2.15% and 1.61%, respectively. The frequency of the FII c.1824T allele was 0.54% in both tissues. Four patients showed different genotypes in tumor and normal tissue.
Conclusion:
Prothrombin 3' end gene variants may play a role in colorectal cancer.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...